AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. GRI
  4. [ARS] GRI Bio, Inc. SEC Filing

[ARS] GRI Bio, Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - GRI Bio, Inc.

AG真人官方

ARS Filing - GRI Bio, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: GRI Bio, Inc. (GRI)

Acceptance Date: 2025-07-11T16:20:46.000Z

Source:

Stock GRI logo
GRI Bio

NASDAQ:GRI

GRI Rankings

#6424 Ranked by Market Cap
N/A Ranked by Dividends
#166 Top Gainer

GRI Latest News

Aug 14, 2025
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Jul 31, 2025
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor 鈥淲hat This Means鈥� Segment
Jul 31, 2025
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (鈥淚PF鈥�)聽
Jul 22, 2025
GRI Bio Participates in the Virtual Investor 鈥淲hat鈥檚 Your Story鈥� Summer Spotlight On-Demand Conference
Jul 1, 2025
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (鈥淚PF鈥�)

GRI Latest SEC Filings

Aug 14, 2025
[10-Q] GRI Bio, Inc. Quarterly Earnings Report
Aug 13, 2025
[S-8] GRI Bio, Inc. Employee Benefit Plan Registration
Aug 13, 2025
[8-K] GRI Bio, Inc. Reports Material Event
Jul 31, 2025
[8-K] GRI Bio, Inc. Reports Material Event
Jul 11, 2025
[DEF 14A] GRI Bio, Inc. Definitive Proxy Statement

GRI Stock Data

2.91M
2.50M
0.02%
0.2%
5.16%
Biotechnology
Pharmaceutical Preparations
United States
LA JOLLA